Keyphrases
Vascular Complications
100%
Murine Model
100%
Type I Diabetes
100%
Type 1 Diabetes Mellitus (T1DM)
100%
Annexin A1 (ANXA1)
100%
AKT Pathway
100%
Nephropathy
28%
Renal Disease
21%
Diabetic
21%
Diabetic Mice
21%
Phosphorylation
14%
Cardiac Dysfunction
14%
Inflammation
14%
Non-diabetic
14%
Plasma Parameters
14%
Kidney
14%
Wild Mice
14%
Renal Function
14%
Cardiomyopathy
14%
Proteinuria
14%
Recombinant
14%
Experimental Diabetes
14%
Sodium Chloride
14%
C-Jun N-terminal Kinase
14%
Extracellular Signal-regulated Kinase
14%
HEPES
14%
Cardiac Ejection Fraction
14%
STZ-induced
14%
Mouse Model
7%
C57BL
7%
Comorbidity
7%
Therapeutic Potential
7%
Potential Therapeutics
7%
Healthy Individuals
7%
Prophylactic Treatment
7%
Consecutive Days
7%
Mitogen-activated Protein Kinase
7%
Cardiac Function
7%
Healthy Donors
7%
Streptozotocin
7%
Functional Decline
7%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
7%
Akt Phosphorylation
7%
Pro-survival
7%
STZ-induced Diabetes
7%
Anti-inflammatory Molecules
7%
Bedside to Bench
7%
Immunology and Microbiology
Blood Level
100%
Wild Type Mouse
100%
Kidney Function
100%
Heart Ejection Fraction
100%
Mitogen
100%
Amino Terminal Sequence
100%
Akt Signaling
100%
Blood Plasma
50%
Mouse Model
50%
Heart Function
50%
Comorbidity
50%
INIS
mice
100%
restoration
100%
kidneys
80%
kinases
60%
levels
30%
comparative evaluations
30%
inflammation
30%
phosphorylation
30%
plasma
30%
humans
20%
administration
20%
phosphorus 38
20%
proteins
20%
signals
20%
vehicles
20%
mitogens
20%
ph value
20%
sodium chlorides
20%
control
10%
injection
10%
phenotype
10%
molecules
10%
hypothesis
10%
streptozotocin
10%
Medicine and Dentistry
Insulin Dependent Diabetes Mellitus
100%
Microvascular Complication
100%
Lipocortin 1
100%
Akt Signaling
100%
Diabetes Mellitus
36%
Nephropathy
36%
Mitogen-Activated Protein Kinase
27%
Myocardial Disease
18%
Kidney Function
18%
Phosphotransferase
18%
Ejection Fraction
18%
Amino Terminal Sequence
18%
Proteinuria
18%
HEPES
18%
Heart Function
9%
Anti-Inflammatory Drug
9%
Prophylaxis
9%
Streptozocin
9%
C57BL/6
9%
Streptozotocin-Induced Diabetes Mellitus
9%
Kinase Signaling
9%
Recombinant
9%
Mitogen Activated Protein Kinase P38
9%
Comorbidity
9%
Pharmacology, Toxicology and Pharmaceutical Science
Insulin Dependent Diabetes Mellitus
100%
Lipocortin 1
100%
Diabetes Mellitus
36%
Kidney Disease
36%
Mitogen Activated Protein Kinase
27%
Inflammation
18%
Myocardial Disease
18%
Wild Type Mouse
18%
Phosphotransferase
18%
Proteinuria
18%
HEPES
18%
Anti-Inflammatory Drug
9%
Mouse Model
9%
Streptozotocin
9%
Mitogen Activated Protein Kinase P38
9%
Streptozotocin-Induced Diabetes Mellitus
9%
Recombinant
9%
Comorbidity
9%